BREVICON 1/35 21 TAB .035 MG
ETHINYL ESTRADIOL : .035 MG NORETHINDRONE : 1 MG · DIN 00531006 · SYNTEX INC.
Health Canada status: CANCELLED POST MARKET
What is BREVICON 1/35 21 TAB?
BREVICON 1/35 21 TAB .035 MG contains ETHINYL ESTRADIOL : .035 MG NORETHINDRONE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 00531006, held by SYNTEX INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 30-Sep-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00531006 |
|---|---|
| Brand name | BREVICON 1/35 21 TAB |
| Generic / active ingredient | ETHINYL ESTRADIOL : .035 MG NORETHINDRONE : 1 MG |
| Manufacturer | SYNTEX INC. |
| Strength | .035 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | G03AA05 NORETHISTERONE AND ESTROGEN |
| AHFS class | 68:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 30-Sep-1996 |
| Original market date | 1982-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code G03AA05 NORETHISTERONE AND ESTROGEN. 6 of 25 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BREVICON 0.5/35 TABLETS (21-DAY PACK) | 0.5 MG | TABLET | PFIZER CANADA ULC | MARKETED | DIN 02187086 |
| BREVICON 0.5/35 TABLETS (28-DAY PACK) | .5 MG | TABLET | PFIZER CANADA ULC | MARKETED | DIN 02187094 |
| BREVICON 1/35 TABLETS (21-DAY PACK) | 1 MG | TABLET | PFIZER CANADA ULC | MARKETED | DIN 02189054 |
| BREVICON 1/35 TABLETS (28-DAY PACK) | 1 MG | TABLET | PFIZER CANADA ULC | MARKETED | DIN 02189062 |
| SELECT 1/35 (21-DAY) | 1.0 MG | TABLET | PFIZER CANADA ULC | MARKETED | DIN 02197502 |
| SELECT 1/35 (28-DAY) | 1.0 MG | TABLET | PFIZER CANADA ULC | MARKETED | DIN 02199297 |
| BREVICON 0.5/35 21 TAB | .035 MG | TABLET | SYNTEX INC. | CANCELLED POST MARKET | DIN 00373265 |
| BREVICON 0.5/35 28 TAB | .5 MG | TABLET | SYNTEX INC. | CANCELLED POST MARKET | DIN 00373273 |
| BREVICON 1/35 28 TAB | .035 MG | TABLET | SYNTEX INC. | CANCELLED POST MARKET | DIN 00531014 |
| GENERESS | 0.025 MG | TABLET (CHEWABLE) | ALLERGAN INC | CANCELLED PRE MARKET | DIN 02435659 |
Who else supplies NORETHISTERONE AND ESTROGEN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NORETHISTERONE AND ESTROGEN appears in 14 registered pack listings across 8 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.